{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T19:05:17Z","timestamp":1786993517685,"version":"build-2736575974"},"reference-count":28,"publisher":"Oxford University Press (OUP)","issue":"11","license":[{"start":{"date-parts":[[2020,8,13]],"date-time":"2020-08-13T00:00:00Z","timestamp":1597276800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"},{"start":{"date-parts":[[2020,8,13]],"date-time":"2020-08-13T00:00:00Z","timestamp":1597276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["jsm.jsexmed.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2020,11,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Priapism is a urologic emergency consisting of a painful erection lasting greater than 4\u00a0hours; antithrombotic therapy (ATT) have recently been recommended as an adjunct in the treatment of ischemic priapism.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Aim<\/jats:title>\n                    <jats:p>To determine the short- and long-term outcomes of periprocedural ATT in the management of acute ischemic priapism.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A retrospective review of patients seen at the University of California, San Francisco, from 2008 to 2019 was carried out to identify those evaluated for acute priapism. Information regarding duration of priapism, etiology, treatment, periprocedural and postprocedural ATT type and dose, and follow-up data was collected.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Outcomes<\/jats:title>\n                    <jats:p>ATT use was the exposure of interest; outcome variables included priapism resolution, repeat episodes, long-term complications, and follow-up.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>70 patients with at least 1 detailed record of an acute priapism episode between 2008 and 2019 were identified. Of the 70 patients who underwent management for an acute episode of priapism, 59 (84%) received intracavernous injection of phenylephrine with or without corporal aspiration. Of the 4 patients who received ATT at the same time as intracavernous injection, none had additional priapism episodes. In the 55 patients who did not receive immediate ATT, 22 (40%) required at least 1 shunting procedure. The 9 patients who received ATT concurrently with shunting experienced less recurrence than the 13 patients who did not receive ATT (11% vs 69%, respectively P\u00a0=\u00a0.012). There were no significant differences in long-term erectile dysfunction (P\u00a0=\u00a0.627), fibrosis (P\u00a0=\u00a0.118), genitourinary pain (P\u00a0=\u00a0.474), and urinary issues (P\u00a0=\u00a0.158) between those who received ATT and those who did not.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Clinical Implications<\/jats:title>\n                    <jats:p>Our findings suggest that ATT has a role in preventing priapism recurrence; we observed that long-term repeat priapism episodes are less frequent in those who received periprocedural ATT compared with those who did not and that ATT may especially reduce recurrence in cases when shunting was required<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Strengths &amp; Limitations<\/jats:title>\n                    <jats:p>This is the first study looking at the clinical outcomes of periprocedural ATT in the management of ischemic priapism. It is limited by the fact that it is a single-center study, types of ATT were heterogenous, and the exact timing of priapism management could not be measured for everyone.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>In spite of its limitations, these preliminary findings are promising and warrant further exploration of the use of ATT in the management of ischemic priapism.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1016\/j.jsxm.2020.07.013","type":"journal-article","created":{"date-parts":[[2020,8,14]],"date-time":"2020-08-14T07:37:47Z","timestamp":1597390667000},"page":"2260-2266","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"title":["Clinical Outcomes of Periprocedural Antithrombotic Therapy in\u00a0Ischemic Priapism Management"],"prefix":"10.1093","volume":"17","author":[{"given":"Joris J.","family":"Ramstein","sequence":"first","affiliation":[{"name":"Department of Urology , San Francisco, CA , USA"},{"name":"University of California - San Francisco , San Francisco, CA , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Austin","family":"Lee","sequence":"additional","affiliation":[{"name":"Department of Urology , San Francisco, CA , USA"},{"name":"University of California - San Francisco , San Francisco, CA , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew J.","family":"Cohen","sequence":"additional","affiliation":[{"name":"Department of Urology , San Francisco, CA , USA"},{"name":"University of California - San Francisco , San Francisco, CA , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nnenaya A.","family":"Mmonu","sequence":"additional","affiliation":[{"name":"Department of Urology , San Francisco, CA , USA"},{"name":"University of California - San Francisco , San Francisco, CA , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natalie","family":"Rios","sequence":"additional","affiliation":[{"name":"Department of Urology , San Francisco, CA , USA"},{"name":"University of California - San Francisco , San Francisco, CA , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthony","family":"Enriquez","sequence":"additional","affiliation":[{"name":"Department of Urology , San Francisco, CA , USA"},{"name":"University of California - San Francisco , San Francisco, CA , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alan W.","family":"Shindel","sequence":"additional","affiliation":[{"name":"Department of Urology , San Francisco, CA , USA"},{"name":"University of California - San Francisco , San Francisco, CA , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tom F.","family":"Lue","sequence":"additional","affiliation":[{"name":"Department of Urology , San Francisco, CA , USA"},{"name":"University of California - San Francisco , San Francisco, CA , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin N.","family":"Breyer","sequence":"additional","affiliation":[{"name":"Department of Urology , San Francisco, CA , USA"},{"name":"University of California - San Francisco , San Francisco, CA , USA"},{"name":"Department of Biostatistics and Epidemiology , San Francisco, CA , USA"},{"name":"University of California - San Francisco , San Francisco, CA , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2020,8,13]]},"reference":[{"key":"2023011111113164000_bib1","doi-asserted-by":"crossref","first-page":"37","DOI":"10.12688\/f1000research.12828.1","article-title":"Recent advances in the management of priapism","volume":"7","author":"Muneer","year":"2018","journal-title":"F1000Res"},{"key":"2023011111113164000_bib2","first-page":"1318","article-title":"American Urological Association guideline on the management of priapism","volume":"170","year":"2003","journal-title":"J\u00a0Urol"},{"key":"2023011111113164000_bib3","doi-asserted-by":"crossref","first-page":"199","DOI":"10.21037\/tau.2017.01.18","article-title":"Advances in the understanding of priapism","volume":"6","author":"Hudnall","year":"2017","journal-title":"Transl Androl Urol"},{"key":"2023011111113164000_bib4","doi-asserted-by":"crossref","first-page":"93","DOI":"10.3109\/00365599509180545","article-title":"Priapism, its incidence and seasonal distribution in Finland","volume":"29","author":"Kulmala","year":"1995","journal-title":"Scand J Urol Nephrol"},{"key":"2023011111113164000_bib5","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1016\/S0090-4295(01)00941-4","article-title":"Incidence of priapism in the general population","volume":"57","year":"2001","journal-title":"Urology"},{"key":"2023011111113164000_bib6","doi-asserted-by":"crossref","first-page":"S39","DOI":"10.1038\/sj.ijir.3900777","article-title":"Lecture 3","volume":"13","author":"Berger","year":"2001","journal-title":"Int J Impot Res"},{"key":"2023011111113164000_bib7","first-page":"476","article-title":"Priapism: pathogenesis, epidemiology, and management","volume":"7","author":"Broderick","year":"2010","journal-title":"J\u00a0Sex Med"},{"key":"2023011111113164000_bib8","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1038\/aja.2012.83","article-title":"A\u00a0pathophysiology-based approach to the management of early priapism","volume":"15","author":"Kovac","year":"2013","journal-title":"Asian J Androl"},{"key":"2023011111113164000_bib9","first-page":"142","article-title":"The ultrastructure of the erectile tissue in priapism","volume":"135","author":"Spycher","year":"1986","journal-title":"J\u00a0Urol"},{"key":"2023011111113164000_bib10","first-page":"316","article-title":"Should perioperative anticoagulation be an integral part of the priapism shunting procedure?","volume":"2","author":"Lue","year":"2013","journal-title":"Transl Androl Urol"},{"key":"2023011111113164000_bib11","first-page":"471","article-title":"[Coagulation and fibrinolytic activity of blood from the corpus cavernosum]","volume":"63","author":"Rolle","year":"1991","journal-title":"Arch Ital Urol Nefrol Androl"},{"key":"2023011111113164000_bib12","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1046\/j.1365-2125.1998.t01-1-00796.x","article-title":"Case studies in therapeutics: warfarin resistance and inefficacy in a man with recurrent thromboembolism, and anticoagulant-associated priapism","volume":"46","author":"Routledge","year":"1998","journal-title":"Br J Clin Pharmacol"},{"key":"2023011111113164000_bib13","doi-asserted-by":"crossref","DOI":"10.1136\/bcr-2012-007073","article-title":"Anticoagulant-induced priapism progressing to penile gangrene: a devastating complication!","volume":"2012","author":"Nagathan","year":"2012","journal-title":"BMJ Case Rep"},{"key":"2023011111113164000_bib14","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1111\/j.1439-0272.2009.01006.x","article-title":"Heparin and prednisone-associated priapism: two case reports","volume":"43","author":"Xu","year":"2011","journal-title":"Andrologia"},{"key":"2023011111113164000_bib15","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1038\/sj.ijir.3900759","article-title":"Heparin-induced priapism","volume":"13","author":"Bschleipfer","year":"2001","journal-title":"Int J Impot Res"},{"key":"2023011111113164000_bib16","doi-asserted-by":"crossref","first-page":"657","DOI":"10.21037\/tau.2017.07.23","article-title":"Avoiding complications: surgery for ischemic priapism","volume":"6","author":"Reed-Maldonado","year":"2017","journal-title":"Transl Androl Urol"},{"key":"2023011111113164000_bib17","first-page":"S7","article-title":"Clinical aspects of heparin-induced thrombocytopenia and thrombosis and other side effects of heparin therapy","volume":"5 Suppl 1","author":"Bick","year":"2017","journal-title":"Clin Appl Thromb Hemost"},{"key":"2023011111113164000_bib18","doi-asserted-by":"crossref","DOI":"10.1111\/and.12784","article-title":"A\u00a0literature review of antithrombotic and anticoagulating agents on sexual function","volume":"49","author":"Chen","year":"2017","journal-title":"Andrologia"},{"key":"2023011111113164000_bib19","first-page":"963","article-title":"Priapism: an unusual manifestation of warfarin-induced skin necrosis with protein C deficiency","volume":"54","author":"Mahapatra","year":"2006","journal-title":"J\u00a0Assoc Physicians India"},{"key":"2023011111113164000_bib20","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1038\/s41443-017-0008-0","article-title":"Case report: ischemic priapism secondary to tinzaparin","volume":"30","author":"Purnell","year":"2018","journal-title":"Int J Impot Res"},{"key":"2023011111113164000_bib21","doi-asserted-by":"crossref","first-page":"1566.e17","DOI":"10.1016\/j.avsg.2014.01.024","article-title":"A\u00a061-year-old man with disseminated intravascular coagulation: a case report","volume":"28","author":"Wagenh\u00e4user","year":"2014","journal-title":"Ann Vasc Surg"},{"key":"2023011111113164000_bib22","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.ajem.2015.10.029","article-title":"Effect of phenylephrine and terbutaline on ischemic priapism: a retrospective review","volume":"34","author":"Martin","year":"2016","journal-title":"Am J Emerg Med"},{"key":"2023011111113164000_bib23","first-page":"990","article-title":"The hemodynamic effects of intracavernosal phenylephrine for the treatment of ischemic priapism","volume":"15","author":"Sidhu","year":"2018","journal-title":"J\u00a0Sex Med"},{"key":"2023011111113164000_bib24","first-page":"1704","article-title":"Use of high-dose phenylephrine in the treatment of ischemic priapism: five-year experience at a single institution","volume":"13","author":"Ridyard","year":"2016","journal-title":"J\u00a0Sex Med"},{"key":"2023011111113164000_bib25","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/S0049-3848(03)00143-9","article-title":"Clopidogrel and aspirin in the prevention of thromboembolic complications after mechanical aortic valve replacement (CAPTA)","volume":"109","author":"Schlitt","year":"2003","journal-title":"Thromb Res"},{"key":"2023011111113164000_bib26","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/0741-5214(87)90201-1","article-title":"Platelet antagonists eliminate thromboembolic complications of small-diameter polytetrafluoroethylene arterial prostheses","volume":"5","author":"Nordestgaard","year":"1987","journal-title":"J\u00a0Vasc Surg"},{"key":"2023011111113164000_bib27","doi-asserted-by":"crossref","first-page":"2384","DOI":"10.1111\/j.1538-7836.2006.02153.x","article-title":"Prolonged prophylaxis with dalteparin to prevent late thromboembolic complications in patients undergoing major abdominal surgery: a multicenter randomized open-label study","volume":"4","author":"Rasmussen","year":"2006","journal-title":"J\u00a0Thromb Haemost"},{"key":"2023011111113164000_bib28","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1056\/NEJM199711063371901","article-title":"A\u00a0comparison of recombinant hirudin with a low-molecular-weight heparin to prevent thromboembolic complications after total hip replacement","volume":"337","author":"Eriksson","year":"1997","journal-title":"N\u00a0Engl J Med"}],"container-title":["The Journal of Sexual Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1743609520307621?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1743609520307621?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/academic.oup.com\/jsm\/article-pdf\/17\/11\/2260\/48527254\/jsm_17_11_2260.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jsm\/article-pdf\/17\/11\/2260\/48527254\/jsm_17_11_2260.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,9]],"date-time":"2023-02-09T09:47:32Z","timestamp":1675936052000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jsm\/article\/17\/11\/2260\/6973816"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8,13]]},"references-count":28,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2020,8,13]]},"published-print":{"date-parts":[[2020,11,1]]}},"URL":"https:\/\/doi.org\/10.1016\/j.jsxm.2020.07.013","relation":{},"ISSN":["1743-6109","1743-6095"],"issn-type":[{"value":"1743-6109","type":"electronic"},{"value":"1743-6095","type":"print"}],"subject":[],"published-other":{"date-parts":[[2020,11]]},"published":{"date-parts":[[2020,8,13]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Clinical Outcomes of Periprocedural Antithrombotic Therapy in\u00a0Ischemic Priapism Management","name":"articletitle","label":"Article Title"},{"value":"The Journal of Sexual Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jsxm.2020.07.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 International Society for Sexual Medicine. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}